Breca Tracy
Corporate Officer/Principal bei Heparinex LLC
Aktive Positionen von Breca Tracy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Heparinex LLC
 Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Corporate Officer/Principal | - | - |
Karriereverlauf von Breca Tracy
Ehemalige bekannte Positionen von Breca Tracy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Emergent Technologies, Inc.
 Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Private-Equity-Analyst | 23.04.2009 | 30.09.2017 |
Ausbildung von Breca Tracy
| Stephens College | Undergraduate Degree |
| University of Oklahoma | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Emergent Technologies, Inc.
Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Finance |
Heparinex LLC
Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
- Börse
- Insiders
- Breca Tracy
- Erfahrung
